BCRX: Target practice for shorts | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends
BCRX: Target practice for shorts

An SI Board Since August 1999

Posts	SubjectMarks	Bans
96	1	0

Emcee: hedge fund	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
96	>> For someone who has no position, you sure are around a lot. <<	scaram(o)uche	-	11/3/1999
95	<i>I don't own this company. IMO, there are better risk:reward ops in	J.Y. Wang	-	11/3/1999
94	Richard that is not my analysis its from BCRX in the prospectus for the offerin	Wolff	-	11/3/1999
93	Well, they will sell the 2 mill. today. 450k at 10.15am make that 485k.	arpad toth	-	11/3/1999
92	And on the other side of the equation, if disclosures allowed such, it might re	scaram(o)uche	-	11/3/1999
91	Looks like some buying going on! volume over 225k. ps. over 330k	arpad toth	-	11/3/1999
90	If our influenza neuraminidase inhibitor drug candidate, BCX-1812, receives FDA	Wolff	-	11/3/1999
89	Well I will just use a simple supply/demand analysis, given that there is more	Wolff	-	11/1/1999
88	Just what effect does a secondary offering have on a stock's price in the s	Jan	-	11/1/1999
87	well the 2ndary is definately scheduled for this week quote.bloomberg.com	Wolff	-	11/1/1999
86	Very frustrating stock, Wolff. As it was hanging in the 22-24 range, it looked	J.Y. Wang	-	11/1/1999
85	BCRX has lost as much money as it stands to gain from the NA inhibitor compound	Wolff	-	11/1/1999
84	There certainly was not enough volume to indicate buying interest. I think it	jlib	-	10/30/1999
83	So what happened to make it jump today?	J.Y. Wang	-	10/29/1999
82	Biocryst Reports Third Quarter 1999 Financial Results <pre> BIRMINGHAM	Wolff	-	10/21/1999
81	Glaxo says to Britain sell our drug or we will fire your citizens! Companies P	Wolff	-	10/11/1999
80	FOCUS-UK rules against Glaxo flu drug on NHS (NA inhibitor like BCRX compound)	Wolff	-	10/11/1999
79	Do you happen to know the date when these 2.3M share are scheduled to hit the m	lizardK	-	10/8/1999
78	Thanks. At this point, I just want to get out with my ass intact.	J.Y. Wang	-	10/8/1999
77	Smith Barney is supporting it because they are doing the secondary, I can tell	Wolff	-	10/8/1999
76	Volume dying. Chart shows decline. But support at 24 seems to be strong. An	J.Y. Wang	-	10/8/1999
75	39th ICAAC Program On-Line (Results reflect the drug being given to test subje	Wolff	-	9/13/1999
74	6 key points 1) Only 33% of pts. who get the flu contact their doctor within t	Wolff	-	9/7/1999
73	Good job Wolff, BCRX is taking advantage of the current "flu drug" e	lifeisgood	-	9/6/1999
72	Interesting articles and research Wolff. Keep up the good work. Best Regards,	Amit Ghate	-	9/6/1999

Go to reply# or date (mm/dd/yy):